![[Translate to English:]](/fileadmin/_processed_/5/6/csm_willkommen_d34eda0786.png "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/e/1/csm_ueberuns_c1c8cb27e1.png "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/8/5/csm_ACL_11_GrafikFingerTablet_LB8_c4ce258375.jpg "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/b/8/csm_studien_6aaab3c7bf.jpg "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/6/4/csm_publikaitonen_4abdce50fc.png "[Translate to English:]")
Scope
We use relevant software packages to develop the underlying non-linear mixed effects models according to standardized workflows. The developed models are then used for simulations in order to get more insight in the uptake, distribution and effect of a drug in the body, in order to ultimately determine optimal therapeutic strategies such as dosages or dosing regimens. Our methods can also be applied in situations where concentration measurements are sparse, for example in individual cases from therapeutic drug monitoring. The project result can be a final report or an interactive application (shiny app).
Mission
With pharmacometrics as the interface between pharmacology/biology and statistics/mathematics, we pursue the aim of explaining the kinetics and dynamics of drugs to better understand therapeutic outcomes.
Background
Statistical models can be used to predict how a drug will behave in the body, when and for how long it will achieve its effects, and how this will change the course of a disease.
Please contact us if you have any questions about drug concentration modeling:Pharmako.Metrie(at)med.uni-heidelberg.de.
